The Straits Times
AsiaPac · 3 hrs ago
✦ 78✓ Factual
J&J drug Erleada reduces risk of prostate cancer spread, death
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 15/100
ObjectivePartisan
Low partisan intensity — consistent with factual reporting✓ Fair headline
Johnson & Johnson's prostate cancer drug Erleada has demonstrated a 20% reduction in the risk of cancer spread or death in clinical findings.
J&J drug Erleada reduces risk of prostate cancer spread, death
Erleada reduced the risk of the cancer spreading or death by 20 per cent.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!